ZURICH Feb 21 The Swiss blue-chip SMI
was seen opening 0.2 percent higher at 8,535 points on Tuesday,
according to premarket indications by bank Julius Baer
The following are some of the main factors expected to
affect Swiss stocks on Tuesday:
Roche said it received European Union approval of Alecensa
(alectinib) for people with previously treated alk-positive
non-small cell lung cancer.
For more, click on
* Bank Linth said it generated a stable profit of
20.1 million Swiss francs in 2016.
* Kudelski said it has signed an agreement with
Twitter to broaden their relationship and pursue
collaborative opportunities in areas of joint interest.
* Oerlikon said it wants to establish research
partnerships with the Technical University of Munich and with
the Skolkovo Institute of Science and Technology in Russia.
* Thurgauer Kantonalbank said its profit rose 3
percent to 126 milllion Swiss francs last year and it will pay
out a dividend of 2.75 francs per share.
* Walter Meier said net income double to 14.7
million Swiss francs in 2016 and it intends to pay out a
dividend of two francs per share. It will combine its business
with Tobler Haustechnik AG, with UK-based heating and plumbing
distributor Wolseley holding around 39.2 percent and current
largest shareholder Silvan G.-R. Meier holding 33.5 percent
after the transaction. Shareholders will have to vote on a
capital increase at the AGM on March 24.
* Exports from Switzerland rose year-on-year by a real
work-day adjusted 2.3 percent in January to 18.12 billion Swiss
francs, the Federal Customs Office said on Tuesday.
(Reporting by Zurich newsroom)